Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125699263 | 12569926 | 3 | F | 20160613 | 20160810 | 20160719 | 20160816 | EXP | FR-AFSSAPS-PB20160730 | FR-FRI-1000086191 | FOREST | 57.37 | YR | F | Y | 48.00000 | KG | 20160816 | OT | DK | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125699263 | 12569926 | 1 | PS | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | Oral | 20 MG | Y | 21323 | 20 | MG | FILM-COATED TABLET | QD | |||||
| 125699263 | 12569926 | 2 | SS | TEGRETOL | CARBAMAZEPINE | 1 | Oral | 200 MG | Y | 0 | 200 | MG | PROLONGED-RELEASE TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125699263 | 12569926 | 1 | Product used for unknown indication |
| 125699263 | 12569926 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125699263 | 12569926 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125699263 | 12569926 | Abdominal pain upper | |
| 125699263 | 12569926 | Drug reaction with eosinophilia and systemic symptoms | |
| 125699263 | 12569926 | Eosinophilia | |
| 125699263 | 12569926 | Lymphadenopathy | |
| 125699263 | 12569926 | Lymphocyte morphology abnormal | |
| 125699263 | 12569926 | Pruritus | |
| 125699263 | 12569926 | Pyrexia | |
| 125699263 | 12569926 | Rash maculo-papular | |
| 125699263 | 12569926 | Transaminases increased | |
| 125699263 | 12569926 | Vulvovaginal erythema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125699263 | 12569926 | 1 | 20160520 | 20160616 | 0 | |
| 125699263 | 12569926 | 2 | 20160520 | 20160616 | 0 |